GFM
KURA icon

GF Fund Management’s Kura Oncology KURA Stock Holding History

GF Fund Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.2K Sell
1,843
-101
-5% -$953 ﹤0.01% 480
2026
Q1 		$15.8K Buy
1,944
+234
+14% +$2.01K ﹤0.01% 521
2025
Q4 		$17.8K Sell
1,710
-157
-8% -$1.65K ﹤0.01% 520
2025
Q3 		$16.5K Sell
1,867
-124
-6% -$884 ﹤0.01% 509
2025
Q2 		$11.5K Hold
1,991
– – ﹤0.01% 555
2025
Q1 		$13.1K Buy
1,991
+358
+22% +$2.79K ﹤0.01% 531
2024
Q4 		$14.2K Buy
+1,633
New +$23.5K ﹤0.01% 505

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

GF Fund Management's KURA Position: Q2 2026 in Review

GF Fund Management reduced its Kura Oncology (KURA) stake by 5.2% in Q2 2026, selling an estimated $953 and leaving 1,843 shares worth $20.2K. The position accounts for ﹤0.01% of the portfolio, ranked #480.

GF Fund Management first reported a position in KURA in Q4 2024 and has held it in 7 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • GF Fund Management held 1,843 shares of Kura Oncology worth $20.2K as of Q2 2026.
  • GF Fund Management sold 101 Kura Oncology shares in Q2 2026, an estimated $953.
  • Kura Oncology made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #480 holding.
  • GF Fund Management first reported a position in Kura Oncology in Q4 2024 and has held it in 7 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.